Retatrutide, by Soma Pharmaceuticals , is gaining increasing attention as a innovative method for weight regulation. This unique drug integrates the activity of a GLP-1 receptor stimulant and a GIP receptor activator , aiming to not only promote metabolic improvements but also address related metabolic issues . Initial human studies have demonstrat